Jianxin Xue
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 26
- Lung Cancer Research Studies 18
- CAR-T cell therapy research 8
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 10
- Cancer Genomics and Diagnostics 9
-
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 17
- Immunology top 10%
-
- Effects of Radiation Exposure 13
- Journals
- Advanced Materials (3 papers)Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jianxin Xue
127 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 136
- Oncology 815
- Cancer Research 427
- Pulmonary and Respiratory Medicine 787
- Immunology 347
- Radiology, Nuclear Medicine and Imaging 354
Countries citing papers authored by Jianxin Xue
This map shows the geographic impact of Jianxin Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianxin Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianxin Xue more than expected).
Fields of papers citing papers by Jianxin Xue
This network shows the impact of papers produced by Jianxin Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianxin Xue. The network helps show where Jianxin Xue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianxin Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 37 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 27 | |
| 14 | 2022 | 32 | |
| 15 | 2018 | 11 | |
| 16 | 2015 | 35 | |
| 17 | 2014 | 10 | |
| 18 | 2013 | 23 | |
| 19 | 2013 | 40 | |
| 20 | Resveratrol protects against acute radiation-induced lung injury in C57BL mice | 2011 | 1 |
About Jianxin Xue
Jianxin Xue is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (18 papers), Lung Cancer Diagnosis and Treatment (17 papers), Effects of Radiation Exposure (13 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer Genomics and Diagnostics (9 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Oncology (815 citations), Cancer Research (427 citations) and Pulmonary and Respiratory Medicine (787 citations). Jianxin Xue has collaborated with scholars based in China, United States and Germany. Frequent co-authors include You Lü, Mengqian Li, Liting You, Lei Deng, Ruizhan Tong, Feifei Na, Xianming Mo, Lin Zhou, Jie Lan and Yuncong Liu. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.